Samson Cancer Center: 350 Young Ave., Suite 200, Moorestown, NJ 08057 | phone:
350 Young Ave., Suite 200, Moorestown, NJ 08057
640-221-3468
The right care, right here … for you in Burlington County.
The right care,
right here …
for you in
Burlington County.
Comprehensive Cancer Care Tailored to Your Needs
If you’re facing cancer, we are here for you, keeping you close to the people you love, leading the life that you love.
Learn More About Our Advanced Diagnostic Technologies
At Regional Cancer Care Associates (RCCA) of Moorestown, we provide the latest therapies and approaches to treating cancer in a community-based setting that offers:
- A welcoming, comfortable environment.
- Convenience, accessibility and the ability to see the same doctor from one visit to the next.
- Care centered around the patient’s best interests and optimal health.
- Collaboration with our patients’ other physicians.
- Access to clinical trials.
Our expert oncologists and hematologists are here for you throughout your cancer journey, whether you are newly diagnosed, in the midst of treatment, or have completed active treatment and have a question or need follow-up care.
If you’re facing cancer, we are here for you, keeping you close to the people you love, and leading the life that you love.
Learn More About Our Advanced Diagnostic Technologies
Meet Our Team
To make an appointment, please call: 640-221-3468
Seth Berk, MD
Dr. Berk has been treating patients in Burlington County for more than 20 years. He is Board Certified in Internal Medicine, Oncology and Hematology. He obtained a medical degree from Columbia University and a fellowship in Hematology and Oncology at The Hospital of the University of Chicago. During fellowship, he was involved in clinical and laboratory research in the development of new chemotherapy drugs. Dr. Berk is the Section Chief of Hematology/Oncology at Virtua Memorial Hospital.
“RCCA Moorestown was created with the patient in mind. The care our patients receive is warm and compassionate. To the extent that is possible, we want people to experience happiness while they are here.”
Maurice Cairoli, MD
Board Certified in Oncology and Internal Medicine, Dr. Cairoli has a special interest in the treatment of Breast Cancer. He attended the University of Notre Dame, where he received an undergraduate degree. He then obtained a medical degree from New York Medical College. He did a fellowship in Hematology/Oncology at Washington University School of Medicine in St. Louis, where his rotated at Barnes Hospital. He has been treating patients in South Jersey for over 25 years.
“Our size allows us to provide more comprehensive care than a smaller practice can in terms of clinical trials, education, and ancillary services, such as nutrition or access to physical therapy. That’s one of the big advantages that we have to offer.”
James Lee, MD
Dr. Lee has been treating oncology and hematology patients for more than 30 years. He came to the South Jersey area in 2004 and has been treating patients in the area ever since. His medical degree was obtained at Cornell University. He then went to Georgetown University Hospital for his residency, followed by a fellowship at the National Cancer Institute.
"Access to services within the local community is an important factor. When you are a patient of RCCA Moorestown, your oncologist, radiation and supportive treatments like blood transfusions, staff for genetic counseling and social services are all in one building."
Rachel Levenbach, MD
Dr. Levenbach received her medical education at Temple University. During her fellowship at Fox Chase Cancer Center, Temple University, she was involved in clinical research in the areas of breast cancer and gynecological malignancies. Dr. Levenbach is board-certified in hematology, internal medicine, and oncology.
“One of the real benefits of community-based oncology care is that everyone in our office, from the people at the front desk to the nurses and physicians, really comes to know each patient and her or his family personally. That counts for a lot.”
Stephen Wallace, MD
Dr. Wallace is Board Certified in Internal Medicine, Hematology and Oncology. He received a medical degree from the University of Cape Town, South Africa. He completed his residency at Albert Einstein Medical Center, where he served as chief resident and did his fellowship at the Fox Chase Cancer Center, where he served as chief fellow. Dr. Wallace has been practicing in the Burlington County area since 2005.
“Oncology treatments have progressed unbelievably in a very short amount of time, the kind of advances that we see happening before our eyes of symptoms are almost miraculous.”
Our Services
RCCA Moorestown specializes in all aspects of oncology and hematology. We focus on our patients’ health and quality of life, providing a unique approach to their care.
We offer cutting-edge cancer treatments, including immunotherapy, clinical trials, genetic testing, radiation therapy, and more.
Bladder cancer
Medical oncologists work closely with urologists and, often, radiation oncologists to provide comprehensive care of bladder cancer and to offer patients highly individualized care.
Breast cancer
Treatment options for breast cancer have expanded rapidly in recent years, greatly increasing survival rates and enhancing quality of life.
Cervical cancer
Many cases of this gynecological cancer arise from infection with the human papillomavirus (HPV). Vaccination against HPV can reduce risk, but if a woman does develop cervical cancer, several effective treatment approaches can be employed.
Colon cancer
Almost 100,000 people in the U.S. are diagnosed with colon cancer each year. Fortunately, several effective treatment approaches are available.
Kidney cancer
More than 80,000 people across the U.S. are diagnosed with kidney cancer annually. Immunotherapies and targeted therapies are playing a growing role in management of the disease.
Liver cancer
Along with surgery, chemotherapy, and radiation therapy, several new treatment approaches have emerged in recent years for treating liver cancer.
Lung cancer
Lung cancer is responsible for the highest number of cancer-related deaths in the U.S. each year, but real progress is being made against the disease.
Bladder cancer
Medical oncologists work closely with urologists and, often, radiation oncologists to provide comprehensive care of bladder cancer and to offer patients highly individualized care.
Breast cancer
Treatment options for breast cancer have expanded rapidly in recent years, greatly increasing survival rates and enhancing quality of life.
Colon cancer
Almost 100,000 people in the U.S. are diagnosed with colon cancer each year. Fortunately, several effective treatment approaches are available.
Cervical cancer
Many cases of this gynecological cancer arise from infection with the human papillomavirus (HPV). Vaccination against HPV can reduce risk, but if a woman does develop cervical cancer, several effective treatment approaches can be employed.
Kidney cancer
More than 80,000 people across the U.S. are diagnosed with kidney cancer annually. Immunotherapies and targeted therapies are playing a growing role in management of the disease.
Liver cancer
Along with surgery, chemotherapy, and radiation therapy, several new treatment approaches have emerged in recent years for treating liver cancer.
Lung cancer
Lung cancer is responsible for the highest number of cancer-related deaths in the U.S. each year, but real progress is being made against the disease.
Lymphoma
Lymphomas are cancers that begin in immune system cells. They can occur in almost all parts of the body. Recent years have seen major advances in treating the different forms of lymphoma.
Multiple Myeloma
Advances in our understanding of this cancer, which arises in the bone marrow, have greatly improved the outlook for people diagnosed with the condition.
Ovarian cancer
Surgery and chemotherapy are the mainstays of treatment for ovarian cancer, but immunotherapy and other approaches are playing a larger role in care plans.
Pancreatic cancer
Pancreatic cancer, which is diagnosed in about 66,000 people in the U.S. each year, is the subject of intensive research, which is driving steady progress against the disease.
Prostate cancer
About 1 in 8 men will be diagnosed with prostate cancer over the course of their lives. Fortunately, effective medical, surgical, and radiation treatment options are available.
Stomach cancer
Stomach cancer, also known as gastric cancer, is diagnosed in about 26,500 people in the U.S. each year. A range of treatment options are available.
Lymphoma
Lymphomas are cancers that begin in immune system cells. They can occur in almost all parts of the body. Recent years have seen major advances in treating the different forms of lymphoma.
Multiple Myeloma
Advances in our understanding of this cancer, which arises in the bone marrow, have greatly improved the outlook for people diagnosed with the condition.
Ovarian cancer
Surgery and chemotherapy are the mainstays of treatment for ovarian cancer, but immunotherapy and other approaches are playing a larger role in care plans.
Pancreatic cancer
Pancreatic cancer, which is diagnosed in about 66,000 people in the U.S. each year, is the subject of intensive research, which is driving steady progress against the disease.
Prostate cancer
About 1 in 8 men will be diagnosed with prostate cancer over the course of their lives. Fortunately, effective medical, surgical, and radiation treatment options are available.
Stomach cancer
Stomach cancer, also known as gastric cancer, is diagnosed in about 26,500 people in the U.S. each year. A range of treatment options are available.
Benign (non-cancerous) Blood Disorders
In addition to treating solid tumors and cancers of the blood or blood-forming tissues, such as leukemia and lymphoma, RCCA’s hematologists have expertise in managing a wide range of benign blood disorders, including those highlighted below.
Bleeding disorders
Genetics, certain medications, and other factors can interfere with the normal clotting response, leading to excessive bleeding. Bleeding disorders include hemophilia and von Willebrand disease. Recent years have seen great progress in treating these conditions.
Clotting disorders/thrombosis
The body’s ability to control bleeding by forming blood clots is a life-saving function, but in some people, clotting occurs inappropriately, creating the risk that a clot will cause a heart attack or stroke. Anticoagulant therapy can significantly reduce this risk.
Hemochromatosis
Also known as iron overload, hemochromatosis is a condition in which your body stores too much iron. Untreated, it can cause damage to your heart, liver, and pancreas. Fortunately, ongoing medical management can guard against those risks.
Hemolytic anemia and other anemias
In hemolytic anemia, immune-system problems, medications, or other factors can prompt the body to destroy red blood cells. Other anemias can result from other causes. Identifying the underlying cause of anemia guides selection of the optimal treatment.
Bleeding disorders
Genetics, certain medications, and other factors can interfere with the normal clotting response, leading to excessive bleeding. Bleeding disorders include hemophilia and von Willebrand disease. Recent years have seen great progress in treating these conditions.
Clotting disorders/thrombosis
The body’s ability to control bleeding by forming blood clots is a life-saving function, but in some people, clotting occurs inappropriately, creating the risk that a clot will cause a heart attack or stroke. Anticoagulant therapy can significantly reduce this risk.
Hemochromatosis
Also known as iron overload, hemochromatosis is a condition in which your body stores too much iron. Untreated, it can cause damage to your heart, liver, and pancreas. Fortunately, ongoing medical management can guard against those risks.
Hemolytic anemia and other anemias
In hemolytic anemia, immune-system problems, medications, or other factors can prompt the body to destroy red blood cells. Other anemias can result from other causes. Identifying the underlying cause of anemia guides selection of the optimal treatment.
Iron deficiency and iron deficiency anemia
Without sufficient iron, you can’t produce the healthy red blood cells needed to carry oxygen throughout your body. Fatigue and other health problems can result. However, effective oral and intravenous treatments are available.
Leukopenia and leukocytosis
Leukopenia refers to a lower-than-normal white blood cell count, while leukocytosis is the term for a higher-than-normal white blood cell count. With both conditions, finding and managing the cause of the disorder is essential.
Sickle cell disease
Sickle cell disease (SCD) is a group of inherited red blood cell disorders that most often affect African-Americans. RCCA hematologists manage SCD in adult patients to guard health and enhance quality of life.
Vitamin B12 deficiency
Inadequate amounts of vitamin B12 can lead to hematologic and neurologic symptoms. Depending on its cause, this condition can be treated with oral supplements or regular injections.
Iron deficiency and iron deficiency anemia
Without sufficient iron, you can’t produce the healthy red blood cells needed to carry oxygen throughout your body. Fatigue and other health problems can result. However, effective oral and intravenous treatments are available.
Leukopenia and leukocytosis
Leukopenia refers to a lower-than-normal white blood cell count, while leukocytosis is the term for a higher-than-normal white blood cell count. With both conditions, finding and managing the cause of the disorder is essential.
Sickle cell disease
Sickle cell disease (SCD) is a group of inherited red blood cell disorders that most often affect African-Americans. RCCA hematologists manage SCD in adult patients to guard health and enhance quality of life.
Vitamin B12 deficiency
Inadequate amounts of vitamin B12 can lead to hematologic and neurologic symptoms. Depending on its cause, this condition can be treated with oral supplements or regular injections.
Contact Us
Hours
Monday – Friday : 8:30am – 5:30pm
Saturday – Sunday: Closed